[HTML][HTML] Harnessing CRISPR technology for viral therapeutics and vaccines: from preclinical studies to clinical applications

F Zahedipour, F Zahedipour, P Zamani, MR Jaafari… - Virus Research, 2024 - Elsevier
The CRISPR/Cas system, identified as a type of bacterial adaptive immune system, have
attracted significant attention due to its remarkable ability to precisely detect and eliminate …

[HTML][HTML] Application of the CRISPR/Cas9 System to Study Regulation Pathways of the Cellular Immune Response to Influenza Virus

D Prokhorova, N Zhukova, A Lemza, M Sergeeva… - Viruses, 2022 - mdpi.com
Influenza A virus (IAV) causes a respiratory infection that affects millions of people of
different age groups and can lead to acute respiratory distress syndrome. Currently, host …